Published date: 30 September 2022
Closed early engagement
Contract summary
Industry
Business and management consultancy services - 79410000
Location of contract
SW1P 3HX
Procurement reference
CF-1104000D0O000000rwimUAA
Published date
30 September 2022
Closing date
11 October 2022
Contract type
Service contract
Contract is suitable for SMEs?
Yes
Contract is suitable for VCSEs?
Yes
Description
The UK Health Security Agency (UKHSA) is responsible for protecting every member of every community from the impact of infectious diseases, chemical, biological, radiological and nuclear incidents and other health threats. We provide intellectual, scientific and operational leadership at national and local level, as well as on the global stage, to make the nation's health secure.
The Diagnostics and Innovation team has a remit across the United Kingdom to provide Regulatory and Quality support for Covid-19 lateral Flow devices, PCR specimen collection and antiviral kits and related software devices. This is applicable where UKHSA is the legal manufacture of devices or has a significant role in procuring, developing and or distributing Covid-19 medical and IVD devices
The Diagnostics and Innovation unit requires an integrated managed service to meet the Regulatory (MDR 2002 SI618) and MHRA requirements for these devices until no longer required which is anticipated to be 31st March 2024.
Should you wish to respond to this Request for Information, please complete and return the response questionnaire via the messaging section on the following eTendering portal which is found at the following link: https://health-family-contract-search.secure.force.com/ProSpend__CS_ContractPage?SearchType=Projects&uid=a078d000000vng8AAA&searchStr=&sortStr=Recently+Published&page=1&filters=&County=
About the buyer
Contact name
Doug Gilchrist
Address
Noble House, 17 Smith Square
London
SW1P 3HX
GB
Share this notice
Closing date: 11 October 2022
All content is available under the
